文献速递生殖医学

无药物体外激活与腹腔镜卵巢切开术治疗卵巢性不孕的手术方法

Surgical approaches of drug-free in vitro activation and laparoscopic ovarian incision to treat patients with ovarian infertility.
PubMed 文献 · Fertil Steril · 2020-09-06

该视频演示展示了无药物体外激活(IVA)治疗早发性卵巢功能不全(POI)或卵巢储备功能减退(DOR)的四步手术流程,以及腹腔镜卵巢切开术(LOI)治疗抵抗性卵巢综合征(ROS)的单步操作。15例接受无药物IVA的患者中13例窦卵泡数增加,获得更多卵母细胞用于体外受精,并实现1例自然妊娠、4例活产和1例持续妊娠;11例ROS患者中7例经LOI后卵泡生长至排卵前阶段,4例妊娠并获3例健康活产和1例持续妊娠。两种手术均可在腹腔镜下1小时内完成且无并发症。

要点

  • 无药物IVA通过卵巢皮质体外切割破坏Hippo信号促进残留卵泡生长。
  • LOI通过原位切开卵巢皮质破坏Hippo信号,用于治疗抵抗性卵巢综合征。
  • 两种术式均在腹腔镜下1小时内完成且无并发症报告。

核心结论

  • 无药物IVA可促进POI或DOR患者残留卵泡生长,为近期POI或DOR患者提供不孕治疗选择。
  • LOI通过体内破坏Hippo信号可促进ROS患者卵泡生长。

研究设计与样本

  • 研究设计为手术操作步骤的视频演示。
  • POI诊断基于40岁前近期闭经;DOR根据博洛尼亚标准且卵巢刺激后可见少量窦卵泡生长。
  • ROS诊断基于闭经伴高促性腺激素性低雌激素血症,但经阴道超声显示年龄相匹配的窦卵泡数量。

主要发现

  • 15例接受无药物IVA的患者中13例窦卵泡数增加,随后体外受精获卵数增多。
  • 无药物IVA组实现1例自然妊娠,胚胎移植后4例活产和1例持续妊娠。
  • 另有5例患者和1例流产患者冻存胚胎以备未来移植。
  • 11例ROS患者中7例经LOI后卵泡生长至排卵前阶段,可获取成熟卵母细胞用于体外受精。
  • 4例ROS患者妊娠,其中3例健康活产和1例持续妊娠。

关键数值与推荐

  • 无药物IVA包括4步:切除部分卵巢皮质、体外将皮质切成小方块、制作移植口袋、移植卵巢皮质方块。
  • LOI仅一步:原位切开卵巢皮质。
  • 两种手术后均进行卵巢超刺激至少1年。
  • 手术可在腹腔镜下1小时内完成,无并发症。

临床怎么用

  • 无药物IVA适用于近期诊断的POI或DOR患者,可促进残留卵泡生长并提高体外受精获卵数。
  • LOI适用于抵抗性卵巢综合征患者,可促进卵泡生长并获取成熟卵母细胞。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To demonstrate our procedures of drug-free in vitro activation (IVA) for treating patients with premature ovarian insufficiency (POI) or diminished ovarian reserve (DOR), as well as the laparoscopic ovarian incision (LOI) procedure for treating patients with resistant ovary syndrome (ROS). DESIGN: Step-by-step video demonstration of the surgical procedures. SETTING: Fertility clinic and reproductive medicine department. PATIENTS: Women were diagnosed with POI based on recent amenorrhea before 40 years of age or with DOR according to the Bologna criteria, showing growth of a few antral follicles after ovarian stimulation. ROS patients were diagnosed based on amenorrhea with hypergonadotropic hypoestrogenism but showing age-appropriate number of antral follicles under transvaginal ultrasound. INTERVENTIONS: The drug-free IVA consists of the following 4 steps: removing a part of the cortex from one or both ovaries; cutting ovarian cortical pieces into small cubes in vitro; making pockets for ovarian tissue grafting; and grafting ovarian cortical cubes. The LOI procedure consisted of only one step: cutting ovarian cortex in situ. Both procedures were followed by ovarian hyperstimulation for at least 1 year. Informed consent was obtained from patients and approval was granted by the Biomedical Ethics Committee of the International University School of Medicine and the Rose Ladies Clinic. The present clinical trial was carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki). MAIN OUTCOME MEASURE: Follicle growth. RESULTS: These procedures can be completed within 1 hour under laparoscopic surgery. There were no complications. In 13 of 15 patients treated with drug-free IVA, increases in antral follicle numbers were found, followed by a higher number of retrieved oocytes for in vitro fertilization. In addition to one spontaneous pregnancy, embryo transfer allowed four live births and one ongoing pregnancy. Five additional patients and one miscarriage patient have cryopreserved embryos for future transfer. We also found follicle growth to the preovulatory stage in seven of 11 ROS patients who have not responded to any endogenous and exogenous follicle-stimulating hormone stimulations for follicle growth prior to LOI treatment, allowing the retrieval of mature oocytes for in vitro fertilization. Four ROS patients became pregnant, followed by the delivery of three healthy infants and one ongoing pregnancy. CONCLUSION: A drug-free IVA approach provided an infertility treatment for recent POI or DOR patients. This procedure promoted growth of residual ovarian follicles following ovarian tissue fragmentation in vitro, leading to Hippo signaling disruption. Although ROS patients exhibited symptoms of hypergonadotropic hypoestrogenism similar to that of POI patients, they still had multiple secondary follicles. Hippo signaling disruption in vivo based on cutting ovarian cortex using LOI could promote follicle growth. UMIN CLINICAL TRIALS REGISTRATION NUMBER: UMIN000029807.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Tanaka Y, Hsueh AJ, Kawamura K, et al. Surgical approaches of drug-free in vitro activation and laparoscopic ovarian incision to treat patients with ovarian infertility. Fertil Steril. 2020. PMID: 32907748. doi:10.1016/j.fertnstert.2020.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。